MRI-negative PET-negative epilepsy long-term surgical outcomes: A single-institution retrospective review.


Journal

Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089

Informations de publication

Date de publication:
11 2020
Historique:
received: 10 06 2020
revised: 25 09 2020
accepted: 27 09 2020
pubmed: 12 10 2020
medline: 12 10 2021
entrez: 11 10 2020
Statut: ppublish

Résumé

Surgical planning for people with drug resistant non-lesional focal epilepsy can be challenging. Prior studies focus on cases that are only MRI-negative or MRI-negative with PET-positive imaging, but little is known about outcomes in patients with non-lesional findings on both MRI and PET imaging. In this study, we investigate 5-year surgical outcomes in patients who underwent epilepsy surgery for drug resistant MRI/PET-negative focal epilepsy. We collected clinical and testing data on 131 consecutive patients with drug resistant non-lesional epilepsy who were presented at a multidisciplinary epilepsy surgery conference at the New York University Comprehensive Epilepsy Center between 2010 and 2014, and identified those who underwent epilepsy surgery in order to review 5-year surgical outcomes. There were 103 with non-lesional MRI studies, and of these, 22 had corresponding non-lesional PET imaging. 14 MRI/PET-negative patients pursued a surgical treatment option and 9 underwent resections after intracranial EEG. At 5 years, 77.8 % of patients had favorable (ILAE class 1 and 2) outcomes. Most (77.8 %) had focal cortical dysplasia type Ia (FCDIa) on pathology. These findings suggest that with careful planning and patient selection, surgery for patients with drug resistant MRI/PET-negative focal epilepsy can be successful.

Identifiants

pubmed: 33039796
pii: S0920-1211(20)30532-5
doi: 10.1016/j.eplepsyres.2020.106481
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106481

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Jacob Pellinen (J)

New York University Langone Health Comprehensive Epilepsy Center, New York, NY, USA. Electronic address: jacobpellinen@gmail.com.

Ruben Kuzniecky (R)

Northwell Health Epilepsy Program, New York, NY, USA.

Werner Doyle (W)

New York University Langone Health Comprehensive Epilepsy Center, New York, NY, USA.

Orrin Devinsky (O)

New York University Langone Health Comprehensive Epilepsy Center, New York, NY, USA.

Patricia Dugan (P)

New York University Langone Health Comprehensive Epilepsy Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH